Fortis Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-624
Closed -$87K 252
2020
Q1
$87K Hold
624
0.06% 153
2019
Q4
$82K Hold
624
0.05% 190
2019
Q3
$70K Buy
624
+322
+107% +$35.8K 0.03% 198
2019
Q2
$33K Hold
302
0.02% 261
2019
Q1
$39K Buy
+302
New +$36.7K 0.02% 237

Other funds holding LLY

Fortis Advisors's LLY Position: Q2 2020 in Review

Fortis Advisors sold out of Eli Lilly (LLY) in Q2 2020, closing a stake of 624 shares — an estimated $87K sold.

Fortis Advisors first reported a position in LLY in Q1 2019 and held it in 5 quarters. The position peaked at $87K in Q1 2020. 1,764 funds tracked by Wall St. Rank hold LLY as of Q2 2020.

  • Fortis Advisors reported no remaining Eli Lilly position as of Q2 2020 after selling out during the quarter.
  • Fortis Advisors sold 624 Eli Lilly shares in Q2 2020, an estimated $87K.
  • Fortis Advisors first reported a position in Eli Lilly in Q1 2019 and held it in 5 quarters.
  • Fortis Advisors's Eli Lilly position peaked at $87K in Q1 2020.
  • 1,764 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2020.

Based on Fortis Advisors's 13F filing for Q2 2020, filed 13 Aug 2020.